How to Launch an Industry
49 episodes - English - Latest episode: 6 months ago - ★★★★★ - 10 ratingsThe cannabis industry is expanding more rapidly than ever before. Hot on its heels is the emerging psychedelics industry. What comes next? Our podcast brings listeners entertaining and insightful discussions with leaders in science, medicine, and health along with their pioneering business counterparts to discuss research and current events.
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
Life from Mendocino - Part II
October 18, 2023 08:05 - 1 hour - 82.6 MBAn exciting discussion about AI in drug discovery from a highly cross disciplinary group of experts covering natural products chemistry, biotechnology, computer science, intellectual property, and standards. The episode was recorded live in the beautiful surroundings of the Mendocino County coast in northern California. The scenery provided inspiration for the game segment “guess that native plant” and the pop lit segment about ocean based drug discovery. Both excellent warm ups for our ...
Regul-8
August 07, 2023 04:02 - 1 hour - 109 MBThis episode covers the July 27th House Oversight Committee within the Health Care and Financial Services Subcommittee titled “Hemp in the Modern World: The Yearslong Wait for FDA Action”. The group also discusses new data from analyzing Delta-8-THC products on the market. Our resident GMP and standards expert, David Vaillencourt, moderates this episode. We’re also joined by special guest Gillian Schauer, PhD, who testified before the House Oversight Committee. Dr. Schauer is the Executi...
Live from Psychedelic Science - Part III Culture
July 27, 2023 02:38 - 1 hour - 103 MBThe third and final episode of our Live from Psychedelic Science series focuses on culture. Our team interviewed eight speakers and exhibitors from the conference hailing from various walks of life. The episode kicks off with a psychedelics comedian and rolls into discussion with an experienced energy worker. Next we hear from two non-profit leaders whose organizations champion indigenous reciprocity and fund research to combat the opioid epidemic respectively. From there we engage with ...
Live from Psychedelic Science - Part II Business
July 18, 2023 03:05 - 1 hour - 88.5 MBThe second episode of our three part series, Live from Psychedelic Science, focuses on business. We interview seven founders and initiative leaders operating across marketing, legal, standards, drug development, insurance, and ESG. Listeners get the inside scoop from these industry leaders sharing their experience, both personally and professionally, from attending the largest psychedelic conference in modern history. We also hear about challenges they’ve faced and if changes in the indus...
Live from Psychedelic Science - Part I Research
July 11, 2023 04:47 - 1 hour - 85.8 MBThe first episode of our three part series, Live from Psychedelic Science, focuses on research. We interview five leaders in the field whose work runs the gamut from generating novel molecules to patient care. We kick off the episode with back to back chemist entrepreneurs who work at the cutting edge of psychedelic drug development. From there we hear from the psychedelics program manager at one of the world’s largest medical research institutions. Next, we get an international perspect...
How to Launch a Community
June 12, 2023 04:40 - 1 hour - 84.2 MBThis episode features two special guests, David Bronner and Angela Carter, ND, discussing hot topics in drug policy with co-hosts Jahan Marcu, PhD, and Nigam B. Arora, PhD. David Bronner is the CEO of Dr. Bronner’s, the highest scoring B Corp in the world among companies dedicated to positive social and environmental impact over profit motive. Additionally David has been dedicated to the responsible integration of cannabis and psychedelics into global culture since 1995, and on the board o...
HLI Interviews from Psychedelic Therapeutics and Drug Development Conference
June 12, 2023 04:24 - 1 hour - 109 MBWe bring you six interviews with leaders in the psychedelics industry who will be presenting at the Psychedelic Therapeutics and Drug Development Conference taking place in San Francisco on May 15 and 16, 2023. The episode spans a variety of topics, each crucial to the development of psychedelic medicines. We begin with government funded drug discovery research, followed by a look at the clinical research landscape both in academia and industry settings. Next our interviewees discuss lega...
20 Grams
May 01, 2023 05:28 - 1 hour - 115 MBWe welcome a true pioneer of psychedelics science, Dr. David Nichols, to the show. The episode begins with panelists matching quotes about psychedelics to the famous person who gave the quote, and the substance they were referring to. The pop literature segment explores a timeline of psychedelic events from 1990 - present. Dr. Nichols provides a fascinating look into multiple landmark studies that were enabled by his lab’s willingness to synthesize the required psychedelic compounds. For...
Artificial Inflation
April 11, 2023 05:20 - 1 hour - 91.4 MBWe get together for this episode to discuss everything from the legacy of the late Raphael Mechoulam, PhD, to the economics of THC and regulated cannabis. This episode features Joshua Hartsel, PhD and the show begins with a fun look at Dr. Mechoulam’s massive impact on cannabis research. For the second segment, we discuss the issues regarding “THC inflation” - over estimations of potency and lab shopping that are plaguing the industry. This topic inspired the episode cover art which, in a f...
Change the Game
March 06, 2023 08:28 - 1 hour - 93 MBWe host Super Bowl XLVII (2013) winner Kelechi Osemele for a sports focused episode! HLI cast member Anna Symonds weighs in heavily having won both the USA Rugby Division I National Championship and Sydney Premiership Championship. The episode begins with a game reviewing shifting cannabis and psychedelics regulations around the world. Next the group discusses the relationship between elite athleticism and psychedelics, spurred by news that NFL quarterback Aarron Rodgers will speak on his...
Disruptive Realms
February 08, 2023 05:15 - 1 hour - 94.4 MBJoin us as we blend perspectives on modern medical research with valuable lessons learned through other ways of knowing. Dr. Bia Labate, executive director of Chacruna Institute, and Dr. Harry McIlroy, clinical director at BioReset Medical, help us dissect the many challenges of placebo controls when researching psychoactives. We further discuss educational offerings from Chacruna Institute specifically focused on methods of knowledge production in the psychedelics field. We close the epi...
Certified Conscious
December 05, 2022 03:57 - 1 hour - 95.9 MBWe wrap up 2022 with a psychedelics focused episode. Listeners are invited to join the conversation with experts working in legal, standards, research funding, and science aspects of the burgeoning industry. The episode kicks off with a game about infrastructure and the required picks and shovels for building it. We then discuss the importance of standards for psychedelics assisted psychotherapy and the launch of a non-profit organization providing leadership in that area. The episode wra...
Altered States
November 02, 2022 18:12 - 1 hour - 97.4 MBExperts discuss the science of taking the trip out of psychedelics while maintaining the therapeutic benefits, a conversation inspired by a recent article published in Nature. Psychedelics policy is also addressed with a game that tests our guests' knowledge about opposition and support for proposition 122 in Colorado. The show wraps up with a discussion of best practices for performing research on how cannabis may affect the endocannabinoid system. Special thanks to the sponsor of this ep...
Live from Mendocino
October 05, 2022 07:41 - 1 hour - 86.4 MBJoin us for a fun, engaging session where we discuss important issues in cannabis testing, alcohol use, and the psychedelic receptorome. This episode was our first recorded in person, and from the beautiful surroundings of the Mendocino County coast in California. The group welcomes first time guests, epidemiologist Teresa Simon, MPH and integrative medicine doctor Harry McIlroy, MD. Episode’s Group: Jahan Marcu, PhD Harry McIlroy, MD Teresa Simon, MPH Amber Wise, PhD Nigam B. Aro...
Chemical Co-op
September 07, 2022 01:22 - 1 hour - 117 MBThis episode starts with a game that tests your knowledge about cannabis sustainability, the environmental impact of hemp operations, and proposed solutions. For our second segment, we discuss reciprocity and sustainability in psychedelics, inspired by an article recently published in Forbes. For our third segment, Rapid Fire Science, we discuss a peer reviewed article, on the serotonin theory of depression, also often referred to as the chemical imbalance theory. Episode’s Group: Jahan Ma...
House of Serotonin
August 01, 2022 05:45 - 1 hour - 110 MBThe group discusses cannabis education, happenings at the FDA, and serotonin syndrome related to psychedelics. There are increasing numbers of universities and colleges offering professional programs and even degrees in cannabis-related areas. Play our game to find the best higher education program for you! In the news segment we dive into surprising big pharma activities with engaging the FDA on cannabis regulations. The show wraps up discussing a review of clinical and mechanistic evidence...
Redefining Drug Pipelines
July 05, 2022 06:38 - 1 hour - 86.9 MBJoin us for a conversation about novel drug substances! The topics range from clinical research to the forces within the cannabis industry’s patent and intellectual property issues. In this episode’s game, Dr. Marcu reads clues about cannabis news and political events, and participants have to guess the fake canna-news article. For the news segment, we discuss 18 psychedelics clinical trials that have received significant media attention, and whether they can possibly deliver on the hype....
Agonize This!
June 05, 2022 19:09 - 1 hour - 96.9 MBJoin us for a psychedelics-focused conversation! Listeners of this podcast episode will enjoy discussions about the basics of serotonin and dopamine, mechanisms of action for psychedelics and antidepressants, different types of patents and their implications, and a dissection of clinical data on the subjective effects of LSD and psilocybin. In this episode’s game, Dr. Marcu reads a statement about a drug and panelists guess if it's in reference to a psychedelic compound or an antidepressan...
NextGen
May 02, 2022 05:24 - 1 hour - 85.8 MBJoin us for a cannabis-focused episode. Our discussion covers some of the politics around federal legalization in the United States, DEA licensed cultivation operators, and research into the potential for cannabis markets in Ukraine and other parts of Eastern Europe. The episode includes discussion about recent trends regarding cannabis and hemp policy in Eastern Europe, a knowledge and attitude surveys of Ukrainians regarding cannabis, and how new hemp and cannabis regulations in the Ukrain...
To Research or to Recall
April 10, 2022 23:41 - 1 hour - 132 MBThis episode features Jackie von Salm, PhD, Anna Symmonds, MA, Jahan Marcu, PhD and Nigam B. Arora, PhD. The podcast starts with a game about cannabis mergers, testing our guest’s knowledge of the recent merger between Cresco Labs and Columbia Care. Then the group buckles up for a discussion about risks related to cannabis-based vape products, and new research investigations on user experiences with various psychedelic substances. Episode’s Group: Jahan Marcu, PhD (moderator) Nigam B. Ar...
Metaphysical COA
March 07, 2022 20:06 - 1 hour - 92 MBAmber Wise, PhD, hosts this episode. Dr. Wise moderates a discussion between Miyabe Shields, PhD, Julie Kowalski, PhD, Nigam B. Arora, PhD, and Jahan Marcu, PhD. The group shares insights into psychedelics based health care as well as discussing issues related to the cannabis industry such as the common mistake everyone makes when miscalculating total THC. We turn to the peer reviewed literature to examine data on whether or not psychedelics can change your religious beliefs and the latest g...
License to Synthesize
February 23, 2022 06:29 - 1 hour - 89.8 MBJahan Marcu, PhD and Nigam B. Arora, PhD are joined by Sara Jane Ward, PhD and Jim Mitchell, PhD the Vice President, API Research and Development at Benuvia Manufacturing. The discussions begin with a deep dive into cannabis and psychedelics policy and research developments, highlighting that it feels as though psychedelics are skipping the line, passing cannabinoids, into the regulatory party. For rapid fire science we discuss cutting technology around synthesizing psychedelic compounds and...
Psychedelics In, Drug Testing Out
February 07, 2022 05:09 - 1 hour - 79.3 MBJahan Marcu, PhD moderates the discussion with Nigam B Arora, PhD, David Vaillencourt, MSc from the GMP collective with special guest Gene Ray MSc, Lab Manager at Garden Remedies. We discuss new research on stupidity, psychedelic healthcare investments, and how drug testing culture has permeated many levels of society. FOr our research article review, we rapid fire our thoughts about ibogaine and the behavioral economics on the demand and use of cannabis. Stick around for our newest game, “D...
Enter the Emulsions
January 24, 2022 07:23 - 1 hour - 79.9 MBJahan Marcu, PhD and Nigam B. Arora, PhD host a conversation with Vertosa’s CSO Harold Han, PhD and their Chief Innovation Officer, Austin Stevenson, MSc. In this episode we focus on how cannabis and psychedelics companies keep their businesses moving forward with fundraising, partnerships, and expanding operations. Join us for an extensive discussion on how experts expand cannabis and hemp businesses. We explore the pros and cons of making a quick buck or having ownership in different types...
Boundless ESG
January 10, 2022 03:59 - 1 hour - 77.8 MBToday’s discussion features Jahan Marcu, PhD, Nigam B. Arora, PhD, David Vaillencourt, MSc., with special guests Kim Napoli, JD, and Marc Ross, JD from the law offices of Vicente Sederberg. We start off by discussing news around the FDA and CBD. Then Marc Ross shares insights into his article “Environmental, Social, & Governance: The Perfect Storm for the Cannabis Industry.” This leads to a social equity discussion that casts a wide net and Kim Napoli offers advice for companies about gettin...
Sporting Deuterium
December 13, 2021 05:50 - 1 hour - 133 MBMarcu & Arora are joined by Anna Symonds, former professional athlete, and the renowned cannabis chemist Dr. Amber Wise. The group discussion focuses on two main topics for this episode. Each are interwoven throughout, starting with public perceptions of psychedelic research, and the factors that influence those perceptions. The other main topic is the use of cannabis in sports. This episode’s game will test your knowledge about THC-O-Acetate. Thanks to this episode’s sponsor The GMP Collec...
From Indigenous to FDA
September 27, 2021 05:31 - 1 hour - 91.2 MBA global episode, with Dr. Jahan Marcu in NYC, Dr. Nigam B Arora in the San Francisco, Sarah Russo in Spain, Sara Jane Ward in Philadelphia, and Joseph Mays in Washington DC. The group discusses our modern myths about the ancient use of psychedelics. Followed by discussions about the implications of a former FDA official joining a major psychedelics company, and water use research on cannabis. For the peer reviewed section of the show the group discusses the psilocybin research pipeline and ...
Sensing Psychedelics
September 12, 2021 21:12 - 1 hour - 81.1 MBJoin us for a great trip centered around regulatory and scientific decision making. The discussions focus on data vs opinion, in our exploration of the latest news and research. Our big story for this episode is about technology that allows researchers to develop psychedelic medicines, and we host two expert guests to speak on the topic. Dr. Jackie von Salm was recently featured in the Wall Street Journal utilizing a technology platform for psychedelic drug development and Dr. Franklin King ...
The IP of Consciousness
August 18, 2021 02:18 - 1 hour - 85.2 MBGet lost in thought as we discuss patents on psychedelics, and IP issues related to drug combinations. But first we dive into the pros and cons of legalizing magic mushrooms in Canada, the psychological risks of meditation, and an uncertain future for smokable CBD products. For our peer reviewed research discussion, we review data regarding “fickle federal policy” and neural correlates of the shamanic state. This episode features Graham Pechenik, JD, a cannabis and psychedelics patent attorn...
Psychedelic Quality of Life
August 02, 2021 21:47 - 1 hour - 83.9 MBThe group is joined by Etienne Fontan and Sabrina Fendrick of Berkeley Patients Group (BPG) where they serve as the Vice President and Chief Public Affairs Officer (and part time miracle worker) respectively. We discuss cannabidiol (CBD) and the liver, Vice’s coverage of the drug PCP, and a commentary article about trends in psychedelics use between women and men. Highlights of the episode include our lively discussion about Delta-8-THC, and a published study exploring physical health and li...
Receptor Talk
July 14, 2021 06:06 - 1 hour - 84.2 MBWe discuss a new research publication on cannabis hyperemesis from Dr. Ethan Russo and Nishi Whiteley, and a review article on serotonin receptors & psychedelics. This episode also offers the opportunity to learn the answers to important questions like, what are the potential risks and benefits of naturalistic mescaline use and what are non-psychedelic psychedelics? We also discuss indigenous populations and maple syrup. The show ends with a new game, Name that Drug! - Dr. Marcu reads a case...
Profit and Laws
June 15, 2021 03:22 - 1 hour - 77.4 MBThe group welcomes back guests Rod Kight and Jocelyn Sheltraw, international cannabis attorney and Director of Industry Relations at Headset respectively. We examine the recent legalization of cannabis in Mexico from several angles with Rod having recently relocated there to work on the ground and Jocelyn sharing projected first year sales. Other topics include the psychedelics patent race, potential uses for cannabis tax proceeds, an examination of the recent vaporizer shipping ban, and a l...
How to Launch an Ecosystem
June 02, 2021 02:37 - 1 hour - 132 MBThe group is joined by Nicole Howell, an attorney, psychonaut, and author in the psychedelics space. Nicole shares her experiences with helping to create new psychedelics legislation and policies with Jahan Marcu, PhD, Nigam B. Arora, PhD, Sara Ward, PhD, and David Vaillencourt, MSc. The discussion ranges from ways to incentivize private companies to invest in research, cannabis dinners in Thailand, research on predicting human responses to psychedelics, and data on the impact of cannabis us...
Room to Grow
May 17, 2021 19:07 - 1 hour - 150 MBIn this episode Amber Wise, PhD, joins the group discussion with Jahan Marcu, PhD, Nigam Arora, PhD, and Sara Jane Ward, PhD. We share our thoughts on federal agencies’ views regarding hemp use in employees and contractors, trends in psychedelics and mental health, and cannabis proficiency testing (aka PT). As well as a story about what it is like to use psychedelic drugs as a participant in a clinical study. For our peer reviewed research articles we discuss recent data on the stability of...
A.I. Surfing Psychedelic Waves
April 12, 2021 04:05 - 1 hour - 101 MBDr. Sara Jane Ward steps up to deliver one of the most unique episodes of HLI yet! Dr. Ward brings us two new and amazing members of the podcast crew, Dr. Deb Kimless and Dr. Del Potter. Dr. Kimless shares her experiences from working as a clinical cannabis researcher in the industry. Dr. Potter shares his views from his work in psychedelics drug R&D, informed by his extensive studies of psychedelics use among indigenous populations. Overall, a fun filled show exploring almost every aspect o...
Live Long and Process
March 29, 2021 04:22 - 1 hour - 84.4 MBDavid Vaillencourt, MSc, CEO and Founder of the GMP Collective, hosts this episode featuring guest appearances by The Spock of Cannabis aka Darwin Millard, Jason Soroosh, MSPH, RD, Jahan Marcu, PhD, and Nigam B. Arora, PhD. David moderates a great discussion around veterinary medicine and CBD, FDA warning letters, ketamine assisted psychotherapy, exercise and chronic cannabis consumption, and the stability of cannabinoids under thermal degradation. Trichome fans won't want to miss out. Thi...
Jazzed on GW?
March 15, 2021 04:33 - 1 hour - 109 MBFounder and CEO of Credo Science Dr. Ethan Russo (also former Senior Medical Advisor at GW) shares his insights about the acquisition of GW Pharmaceuticals and discusses his experiences in cannabis drug development. Dr. Deb Kimless also joins the discussion to explore issues around psychedelics patents and the preservation of psychedelics producing fauna which ties into a book Dr. Russo authored 20 years ago about saving the rainforest (link below). Our scientific articles explore innovativ...
Tripping over Capitalism
March 01, 2021 06:14 - 1 hour - 99.6 MBCan we reimagine capitalism to incentivize companies that support research and sustainability? Are the CBD products out there safe and effective? Are there any differences between synthetic or natural terpenes? The Chief Public Affairs Officer from Berkeley Patients Group, Sebrina Fendrick, joins the group for this discussion. We celebrate Sabrina’s 6 year anniversary at Berkeley Patients Group by digesting new data about cooking with cannabis and treating autoimmune disorders with psychedel...
Meditation and Music as Psychedelics
February 16, 2021 01:59 - 1 hour - 113 MBFounder and CEO of Via Innovations, Monica Vialpando, PhD, joins us for a critical look at the DEA potentially awarding more federal cannabis licenses. We explore the geriatric use of ayahuasca, followed by a look at the psychedelics decolonization movement. And we discuss the pros and cons of yoga and cannabis use. We travel through published scientific articles on meditation and music can influence drug experiences and perhaps, health outcomes. The episode concludes with a fun game, “Gues...
The Revolution will not be Microdosed
February 01, 2021 07:13 - 1 hour - 97.3 MBThe group is joined by Tim Schlidt of Palo Santo, a thematic venture capital firm focused on the psychedelics industry. Together we explore a wide range of topics; the default mode network, basics of ayahuasca, the curious cases of jimson weed and imaginary cigarettes, as well as the pivotal role underground psychedelic labs played in laying the foundation for the industry. For Rapid Fire Science, we discuss two peer review articles, one focuses on a review of mescaline and the other on a p...
You Can’t 2C Me
January 18, 2021 05:38 - 1 hour - 70.5 MBThe group is joined by the big minds from Psilera Bioscience, Jackie von Salm, PhD and Chris Witowski, PhD, to discuss everything from species of magic mushrooms, to the formation of a regulator’s cannabis association, to India’s Cannabis-Mania that is gripping Bollywood. Our science discussions focus on new psychoactive substances, and the pharmacology within the breadth of variety of the 2C class of compounds. The show ends with a rousing round of “Where’s Vaillencourt?” A 20 questions sty...
DMT Release and Ketamine Administration
January 04, 2021 02:38 - 1 hour - 85.2 MBThe group is joined by Joceyln Sheltraw, a social justice and cannabis enthusiast, and the Director of Regional Strategy and New Market Expansion for Headset. The show begins with a discussion on the role of the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act and Good Manufacturing Practices (GMPs) in cannabis business sustainability during the Biden administration followed by discussion of the release of DMT during orgasms. The group also examines balancing the introduction...
Clash of the Psychedelics
December 14, 2020 04:19 - 1 hour - 90.7 MBThe group discusses the dichotomy between patenting psychedelics compounds and promoting free and open research, the complexities of South American cannabis in Europe, and the 12,000 year old relationship between humans and psychedelics. Rapid fire science looks at the side by side comparison of two hallucinogenic substances and how well various cannabinoids permeate the skin. To conclude the group plays the 20 questions style game, “Guess the Psychedelics or Cannabis Research Institute”. ...
Clinical Candy Flipping and Hallucinogenic Beer
November 30, 2020 03:08 - 1 hour - 89.4 MBThe group discusses hallucinogenic beer with a side of clinical candy flipping and other concepts like use of psychedelic experiences to replace prison sentences and how MDMA may act as a glue for marriages and relationships. Rapid fire science examines the promiscuity of psychedelics and the potential applications of CBD analogs. To end, the group plays the 20 questions style game, “Where’s Vaillencourt?”. Episode’s Group Jahan Marcu, PhD Nigam B. Arora, PhD Sara Jane Ward, PhD David V...
Ketamine Infusions and the Paradigm of Bad Trips
November 15, 2020 19:08 - 57 minutes - 78.7 MBThe group discusses resetting the brain, psychedelics terminology, ketamine infusions, research on the therapeutic usefulness of bad trips, and updates in the field of cannabis product safety. Special guest Kim Napoli, JD, joins HLI to bring valuable insights to the table. The show ends with a 20 questions style game, Guess the Cannabinoid. Episode’s Group Jahan Marcu, PhD Nigam B. Arora, PhD David Vaillencourt, MSc Kim Napoli, JD News Links (1:29): Magic Mushrooms Can Reset Depresse...
Naturalistic Psychedelics, Delta-8 THC, and You
November 02, 2020 05:04 - 1 hour - 62.8 MBNews articles focusing on DEA intimidation related to delta-8 THC, engineering yeast to make psychedelics, and psychedelics use and depression. Scientific publications on the impact of naturalistic psychedelics on drug use and consumer understanding of cannabis labels. The show ends with a game that tests your knowledge of hemp in early warfare. Episode’s Group Jahan Marcu, PhD Nigam B. Arora, PhD Sara Jane Ward, PhD Jason Soroosh, MSPH, RD News Links (1:50): Delta-8 THC or Delta-wait...
Elephants On CBD, Canadians Off Opioids
October 19, 2020 07:02 - 1 hour - 61.7 MBAn elephant is dosed with CBD oil, a look at who’s who in raising psychedelic advocacy funding, Republicans blast Harris over pot record, Canadian cannabis use is associated with reduction in IV opioid use, and cannabis use disorder improves inpatient survival. Our show ends with a game that tests your knowledge on cannabis hyperemesis syndrome. Episode’s Group Jahan Marcu, PhD Nigam B. Arora, PhD Sara Jane Ward, PhD David Vaillencourt, MSc News Links (1:30): Elephant Will Be Given CB...
Psychedelic Healing Centers and CBD Withdrawal
October 05, 2020 07:02 - 1 hour - 59 MBJoin the group for a discussion about a study on CBD withdrawal as well as the latest research from regulators and public health experts on the cannabis edible landscape. We provide commentary on the recent coverage of DEA delays, cannabis product recalls, new guidance for psychedelic healing centers, and a dive into recent issues facing State hemp programs. This episode ends with a game that tests your knowledge about CBD and pharmacists. News Links (1:30): Cannabis Industry News - Who pr...
Dissolvable Psilocybin and Cannabis Fitness
September 21, 2020 17:15 - 1 hour - 62.6 MBJoin the group for a discussion about FDA guidance for cannabis research, updates on new psilocybin delivery forms, as well as research into cannabis and its impact on fitness. Don’t miss the end of the episode, when we play the game “Guess the Psychedelic” with a special surprise guest. Group Jahan Marcu, PhD Nigam B. Arora, PhD Sara Jane Ward, PhD David Vaillencourt Brett Greene (special guest) News Links (1:30): FDA guidance for cannabis clinical trials: https://www.fda.gov/media...